|
T.TH
|
VM inhibition and reducing the speed of matastatic spread is all related to...
|
|
T.TH
|
From 2009. These guys had a peptide ligand for sortilin back then and did...
|
|
T.TH
|
Developed by Daichi Sankyo and still under patent, 6 to 28 times more potent...
|
|
T.TH
|
The situation is clear, volume is very low, even on the day of the last PR on...
|
|
T.TH
|
They push the recent article on TH1902 effect on CSC on Linkedin.
|
|
T.TH
|
What you need is not scientists knowing how to make these PDCs with...
|
|
T.TH
|
Another Canadian company mentionned in the article is Fusion Pharma. They...
|
|
T.TH
|
Yesterday showed that if they finally come with real and clear good news, the...
|
|
T.TH
|
Thera posted something about that on Linkedin today, like they often do with...
|
|
T.TH
|
Tumor growth inhibition, in other words, slowing down growth speed, is not...
|
|
T.TH
|
Wino, It crossed my mind while reading your post about Bicycle Therapeutics...
|
|
T.TH
|
When you talk about toxicity, the MTD is more relevant than the recommended...
|
|
T.TH
|
I will make this argument again, at 300 mg/m2, TH1902 is only 1.3 times the...
|
|
T.TH
|
Again. They explained that they go based on probability that a cancer type...
|
|
T.TH
|
It is so boring to follow Thera, no news, nothing, that I found a link saying...
|
|
T.TH
|
The free docetaxel in the bloodstream at 11% of docetaxel injected alone is...
|
|
T.TH
|
You have more results than only patient #2 now published and it did nothing...
|
|
T.TH
|
They talked about something still using biopsies. They never said a word...
|
|
T.TH
|
Thanks. Wino115 wrote: I hope it continues to keep working on your NETs and...
|
|
T.TH
|
Thank you, much appreciated. SPCEO1 wrote: So glad to hear that good report...
|